PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
Research context
PCAS SA appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Basic Materials
- Industry
- Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
PCAS SA is currently in a long term uptrend where the price is trading 11.1% above its 200 day moving average.
From a valuation standpoint, the stock is 96.6% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.9.
PCAS SA's total revenue sank by 0.0% to $49M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 25.4% to $11M since the same quarter in the previous year.
Based on the above factors, PCAS SA gets an overall score of 3/5.